Proove Biosciences Unveils First Precision Medicine Genetic Test for Painful TMJ Disorder
December 07, 2016 12:00 ET
|
Proove Biosciences
IRVINE, CA--(Marketwired - Dec 7, 2016) - Proove Biosciences, Inc., the Healthcare Decision Company™, is pleased to announce the introduction of its unprecedented Proove TMD Profile test,...
Proove Biosciences Ranked 69th Fastest Growing Company in North America on Deloitte's 2016 Technology Fast 500(TM)
November 16, 2016 13:47 ET
|
Proove
IRVINE, CA--(Marketwired - Nov 16, 2016) - Proove Biosciences, Inc. , the Healthcare Decision Company™, today announced it ranked at number 69 on Deloitte's 2016 Technology Fast...
Proove Biosciences Founder & CEO, Brian Meshkin, Honored by OC Tech Alliance as 2016 "CEO of Outstanding Emerging Technology Company"
October 10, 2016 15:25 ET
|
Proove Biosciences, Inc.
IRVINE, CA--(Marketwired - Oct 10, 2016) - Proove Biosciences, Inc. -- the Healthcare Decision Company™ -- is proud to announce that its CEO and founder, Brian Meshkin, has received a...
Proove Biosciences Founder & CEO, Brian Meshkin, Set to Speak at Executive Next Practices Forum on Healthcare
September 29, 2016 14:09 ET
|
Proove Biosciences, Inc.
IRVINE, CA--(Marketwired - Sep 29, 2016) - Proove Biosciences, Inc.--the Healthcare Decision Company™ -- is proud to announce its participation in this fall's 6th Annual Next...
Proove Biosciences Named One of America's Fastest-Growing Private Companies on 2016 Inc. 500 List
August 17, 2016 12:22 ET
|
Proove Biosciences, Inc.
IRVINE, CA--(Marketwired - Aug 17, 2016) - Proove Biosciences, Inc. -- the Healthcare Decision Company™ -- is an industry pioneer in the convergence of molecular diagnostics and big data...
Brian Meshkin Named Emerging Technology CEO Finalist for Orange County Technology Alliance Innovation Awards
July 21, 2016 13:23 ET
|
Proove Biosciences, Inc.
IRVINE, CA--(Marketwired - Jul 21, 2016) - Proove Biosciences, Inc. is proud to announce that its founder and CEO, Brian Meshkin, has been named an Emerging Technology CEO finalist in the Orange...
Proove Biosciences Introduces Three New Profiles to Help Clinicians Improve Treatment Decisions
July 11, 2016 13:48 ET
|
Proove Biosciences, Inc.
IRVINE, CA--(Marketwired - Jul 11, 2016) - Proove Biosciences, Inc. is pleased to announce the introduction of three new evidence-based tests to support better clinical decision-making for...
Global Pain Therapeutics Market Trends & R&D Insights, 2020
June 30, 2016 05:02 ET
|
Research and Markets
Dublin, June 30, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "The Global Pain Therapeutics Market, 5th Edition: Market Trends & R&D...
Beyond Fifteen Communications Signs New Clients: Astoria at Central Park West and Proove Biosciences
June 28, 2016 14:47 ET
|
Beyond Fifteen Communications
IRVINE, CA--(Marketwired - Jun 28, 2016) - Beyond Fifteen Communications Inc., a full-service public relations and social media marketing agency that combines the range and capability of a large...
Proove Announces Lab Accreditation From the College of American Pathologists (CAP)
May 24, 2016 14:32 ET
|
Proove Biosciences
IRVINE, CA--(Marketwired - May 24, 2016) - Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is pleased to announce it has received accreditation from the...